Drug Trial Radar · NCT07559396
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
Last checked: Nov 20, 2026Latest source record: Jun 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
16
Planned (sponsor's estimate)
Start
May 29, 2026
Primary completion
Jan 4, 2027
Study completion Jan 4, 2027
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- First posted
- Apr 30, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will be conducted to assess the safety and pharmacokinetics of INCB123667 when administered orally to adult participants with severe renal impairment or end stage renal disease.
Conditions
- Renal Impairment
Interventions
INCB123667Drug
Group 1: Single dose administered orally. Group 2: Two single doses administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- PK for plasma INCB123667: CmaxTime frame: Up to approximately 3 months
- PK for plasma INCB123667: AUCtTime frame: Up to approximately 3 months
- PK for plasma INCB123667: AUC∞Time frame: Up to approximately 3 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Floridian Clinical Research
Miami Lakes, Florida · Recruiting
Orlando Clinical Research Center
Orlando, Florida · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.